Unplanned revascularization and major adverse cardiac events in spontaneous coronary artery disease patients: insights from a cardiac center

自发性冠状动脉疾病患者的非计划性血运重建和重大不良心脏事件:来自心脏中心的见解

阅读:1

Abstract

AIM: Spontaneous Coronary Artery Disease (SCAD) is a rare condition that mimics acute coronary syndrome and can lead to serious complications. This study evaluates SCAD characteristics, Major Adverse Cardiac Event (MACE) predictors, revascularization needs, and treatment outcomes. MATERIALS AND METHODS: The single cardiac center, retrospective cohort study analyzed patients diagnosed with coronary artery dissection during coronary angiography between January 2014 and December 2019. RESULTS: Of 86 patients, 24(27.9%) experienced early MACE. Diffuse dissections (62.5% vs. 37.5%, p = 0.027) and ostium-involving dissections (33.3% vs. 8.1%, p = 0.006) were more frequent in the MACE group. Female patients (58.3% vs. 21.0%, p = 0.001) and those with lower pre-procedural ejection fraction (EF) (44.1 ± 13.5 vs. 55.0 ± 8.8, p = 0.004) or higher neutrophil to lymphocyte ratio (NLR) (5.59 ± 3.67 vs. 3.60 ± 2.46, p = 0.005) had a higher risk. Ostium-involving dissections (OR(Odds Ratio) = 9.41, p = 0.024) and low EF (OR = 0.931, p = 0.040) were independent predictors of MACE. Initial medical treatment is associated with higher unplanned revascularization compared to percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) (p = 0.030). Coronary tortuosity (p = 0.006) and spot lesions (p = 0.005) were associated with late revascularization. CONCLUSION: High early MACE after SCAD is associated with female gender, high NLR, and low EF. Diffuse and ostium-involving dissections significantly increase the risk of MACE. Initial treatment has been shown to influence early revascularization. while coronary features like tortuosity predict long-term outcomes. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。